Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: January 18, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Puerarin

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug Puerarin?

Puerarin is an investigational drug.

There have been 6 clinical trials for Puerarin. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2013.

The most common disease conditions in clinical trials are Arthritis, Rheumatoid, Arthritis, and Alcohol Drinking. The leading clinical trial sponsors are Chengdu PLA General Hospital, Mclean Hospital, and The University of Hong Kong.

There are one hundred and seventeen US patents protecting this investigational drug and six hundred and ninety-five international patents.

Recent Clinical Trials for Puerarin
Effect of Puerarin on Heart Health in MenHealth and Medical Research Fund, Hong KongPhase 2
Effect of Puerarin on Heart Health in MenThe University of Hong KongPhase 2
Alveolar Cleft Grafting Using Two Different Alloplastic GraftsCairo UniversityPhase 2

See all Puerarin clinical trials

Clinical Trial Summary for Puerarin

Top disease conditions for Puerarin
Top clinical trial sponsors for Puerarin

See all Puerarin clinical trials

US Patents for Puerarin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Puerarin   Start Trial Engineered rice having alcoholism relief and liver protection function, and preparation method thereof China National Research Institute of Food and Fermentation Industries Co., Ltd. (Beijing, CN) Perfect (China) Co., Ltd. (Guangdong, CN)   Start Trial
Puerarin   Start Trial Multifunctional (meth)acrylate manufacturing method TOAGOSEI CO., LTD. (Tokyo, JP)   Start Trial
Puerarin   Start Trial Method for producing (meth)acrylate TOAGOSEI CO., LTD (Tokyo, JP)   Start Trial
Puerarin   Start Trial Whitening composition and the use thereof INFINITUS (CHINA) COMPANY LTD (Jiang Men, CN)   Start Trial
Puerarin   Start Trial Controlled release dosage form TRIASTEK, INC. (Nanjing, CN)   Start Trial
Puerarin   Start Trial Plant extract composition for reducing topical fat and promoting weight loss as well as applications thereof CALIWAY BIOPHARMACEUTICALS CO., LTD. (New Taipei, TW)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Puerarin

Drugname Country Document Number Estimated Expiration Related US Patent
Puerarin China 102648751 2032-05-02   Start Trial
Puerarin Japan 2015517298 2032-05-02   Start Trial
Puerarin Japan 5957600 2032-05-02   Start Trial
Puerarin World Intellectual Property Organization (WIPO) 2013163940 2032-05-02   Start Trial
Puerarin China 106029628 2034-04-16   Start Trial
Puerarin European Patent Office 3133058 2034-04-16   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.